MODIFICATION BY HARMALINE OF THE EFFECTS OF N-CYCLOPROPYL-P-CHLORO-AMPHETAMINE ON 5-HYDROXYINDOLE CONCENTRATION IN RAT-BRAIN

被引:2
作者
FULLER, RW
HEMRICK, SK
PERRY, KW
机构
[1] The Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana
关键词
D O I
10.1111/j.2042-7158.1979.tb13425.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:53 / 54
页数:2
相关论文
共 8 条
[1]  
Fuller R W, 1978, Ann N Y Acad Sci, V305, P147, DOI 10.1111/j.1749-6632.1978.tb31518.x
[2]  
Fuller R W, 1974, Adv Biochem Psychopharmacol, V10, P195
[3]   ENHANCED SELECTIVITY OF PARGYLINE AS AN INHIBITOR OF TYPE-B MONO-AMINE OXIDASE IN HARMALINE-TREATED RATS [J].
FULLER, RW ;
HEMRICK, SK .
LIFE SCIENCES, 1978, 22 (12) :1083-1086
[4]  
FULLER RW, 1973, RES COMMUN CHEM PATH, V6, P407
[5]  
FULLER RW, 1972, ARCH INT PHARMACOD T, V198, P270
[6]   FURTHER-STUDIES ON EFFECTS OF N-CYCLOPROPYL-PARA-CHLOROAMPHETAMINE IN RAT-BRAIN [J].
FULLER, RW ;
PERRY, KW .
NEUROPHARMACOLOGY, 1977, 16 (7-8) :495-497
[7]  
FULLER RW, BIOCH PHARMACOL
[8]  
MILLER F P, 1970, Biochemical Pharmacology, V19, P435, DOI 10.1016/0006-2952(70)90199-1